4Sc AG 4 SC K ORD SHS/ DE000A3E5C40 /
- - | Chg. - | Volume | Bid6:00:03 AM | Ask6:00:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 54.82 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018